基本信息
views: 138
Career Trajectory
Bio
国家杰出青年科学基金项目获得者,国家万人计划青年拔尖人才、山东省杰青、泰山学者特聘专家。主要从事干细胞与组织工程角膜、糖尿病角膜病变相关的基础和应用基础研究,先后以课题负责人身份承担国家重点研发计划课题1项、国家自然科学基金项目5项,山东省杰青、科技攻关计划等项目5项,参与863项目、973课题等省部级以上项目20余项。发表论文100余篇,代表性论文发表在Adv Funct Mater、J Clin Invest、Diabetes、Stem cells、Invest Ophthalmol Vis Sci等糖尿病、干细胞和眼科权威杂志。获国家科技进步二等奖2 项、山东省科技进步一等奖3项,以首位获得授权国家发明专利8项。与日本大阪大学、瑞典卡罗林斯卡医学院和于默奥大学保持有长期合作研究,兼任中华医学会眼科分会视觉电生理学组委员、中国医师协会眼科医师分会基础研究与临床转化专业委员会委员、海峡两岸医学会眼科分会眼干细胞学组委员,《中华实验眼科杂志》通讯编委,Biomaterials、Stem Cells、IOVS、Exp Eye Res等杂志审稿专家。
Research Interests
Papers共 232 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hongwei Wang,Fangying Song, Xia Qi, Xiaoyu Zhang, Li Ma,Depeng Shi,Xiaofei Bai,Shengqian Dou,Qingjun Zhou,Chao Wei,Bi Ning Zhang, Ting Wang,
Advanced healthcare materialspp.e2401179-e2401179, (2024)
crossref(2024)
Stem cell research & therapyno. 1 (2024): 201-201
Jingyi Wu,Longfang Zhou,Yameng Liu, Xiaowei Zhang, Yuanhang Yang, Xinyuan Zhu,Qianwen Bu, Xinmiao Shan, Jia Yin,Robert N Weinreb,Qingjun Zhou,Xiaojing Pan,
Investigative ophthalmology & visual scienceno. 5 (2024): 32-32
Investigative ophthalmology & visual scienceno. 4 (2024): 30-30
Hongyan Liu,Benxiang Qi, Guanghui Liu,Haoyun Duan,Zongyi Li,Zhaoying Shi,Yonglong Chen,Wai Kit Chu,Qingjun Zhou,Bi Ning Zhang
iScienceno. 6 (2024): 109875-109875
Science China Materialspp.1-12, (2024)
Depeng Shi,Xia Qi,Li Ma, Lihua Zhao,Shengqian Dou, Yao Wang,Qingjun Zhou,Yongfei Zhang,Chao Yang,Hongwei Wang,Lixin Xie
EXPERIMENTAL EYE RESEARCH (2024): 109883-109883
Load More
Author Statistics
#Papers: 233
#Citation: 3820
H-Index: 31
G-Index: 49
Sociability: 6
Diversity: 0
Activity: 3
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn